(1 - 8 von 8
)
GSK Announces CHMP Positive Opinion for Labelling Update to Relvar...
www.finanznachrichten.de
Jonathan Sweeting, SVP and Global Head of Respiratory Franchise GSK, said: "There are many asthma patients in Europe who, despite being adequately controlled on a twice-daily ICS/LABA, are still ...
EU approves label update to Relvar Ellipta in patients with ...
www.pharmabiz.com
— Jonathan Sweeting, SVP and head of global respiratory franchise GSK, said: "Patients with asthma can continue to experience symptoms despite ... › News...
Innoviva, GSK: EU Approves Label Update To Relvar Ellipta ...
www.finanznachrichten.de
Jonathan Sweeting, SVP and Head of Global Respiratory Franchise GSK, said: 'Patients with asthma can continue to experience symptoms despite being adequately controlled and these symptoms can ...
GSK announces labelling update to Relvar Ellipta - Investis
otp.investis.com
— Jonathan Sweeting, SVP and Head of Global Respiratory Franchise GSK, said: Patients with asthma can continue to experience symptoms despite ... › rns_new
sortiert nach Relevanz / Datum